Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07544498Not ApplicableNot Yet Recruiting

PIONEERING XR TECHNOLOGY FOR THE PROMOTION OF RESILIENCE AND MENTAL HEALTH OF THE HEALTHCARE WORKFORCE

Role: collaborator

NCT04268797Not ApplicableUnknown

TMS in Treatment of Schizophrenia Negative Symptoms

Role: lead

NCT03718013Not ApplicableCompleted

Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS)

Role: lead

NCT02773108Completed

Somatic Comorbidities in Psychiatric Patients

Role: lead

NCT02917499Not ApplicableCompleted

Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders

Role: lead

All 5 trials loaded